New T cell–based immunotherapy shows promise for lethal stem cell transplant complication

Putting the patient at the centre of cancer-associated thrombosis treatment decisions

Latest trials and outcomes with new CLL treatments

Developing treatments for indolent non hodgkin lymphoma

DNA repair inhibitors to overcome drug resistance

Drugging the cancer genome to overcome drug resistance

Effectiveness of adjuvant chemotherapy on patients with bladder cancer

ASCO GU 2015 news roundup

Taxane response in prostate cancer may not be influenced by androgen receptor variations

Adjuvant treatment with sorafenib or sunitinib does not improve outcomes in localised renal carcinoma

Implications of using adjuvant sorafenib and sunitinib in unfavourable renal carcinoma

Docetaxel with androgen deprivation therapy combo in hormone-naïve metastatic prostate cancer